Even though previous studies have associated variation in CUX2 with Type 1 diabetes, coronary artery disease, atrial fibrillation and most recently with AAM [22,53–55], our novel signals appear to be distinct and infrequent in populations of European descent. This evidence concerns the gene CUX2 and atrial fibrillation.